Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs Metoclopramide for Vomiting in Gastroenteritis
NCT01165866Phase 4Completed
- Sponsor
- Hamad Medical Corporation
- Start
- Jun 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ondansetron in Vomiting (2 arms), sponsored by Hamad Medical Corporation. Primary endpoint: Proportion of patients with cessation of vomiting at 1 year. Started Jun 2008; status: completed.
02
Drugs
ondansetron
03
Conditions
Vomiting
Beyond the preview
Go deeper on NCT01165866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165866.